Skip to Main Content
Legislation Search

H.R. 4101: Cancer Drug Parity Act of 2025

The Cancer Drug Parity Act of 2025 aims to amend the Employee Retirement Income Security Act of 1974 to establish rules regarding the cost-sharing of oral anticancer medications. Here are the main points of the bill:

Purpose

The bill intends to ensure that health insurance plans provide cost-sharing for oral anticancer drugs that is as favorable as the costs associated with intravenous or injectable anticancer drugs administered in a healthcare setting.

Key Provisions

  • Cost-Sharing Parity: Insurance plans must treat oral anticancer medications the same as other anticancer treatments. If a plan covers drugs given by a healthcare provider, it must also offer similar terms for prescribed oral anticancer drugs.
  • Medically Necessary Treatments: The bill applies only to those oral anticancer medications that are deemed medically necessary by a physician. This includes drugs that are approved by the FDA and are necessary for killing, slowing, or preventing the growth of cancerous cells.
  • No Increased Costs: Plans cannot make changes that would result in higher out-of-pocket costs for patients regarding anticancer medications. This includes restrictions that could impose more costly measures for orally administered medications compared to those administered by a provider.
  • Utilization Controls: The bill does not prevent insurance plans from utilizing prior authorizations or other appropriate methods of controlling the use of anticancer drugs.
  • State Law Protections: If a state law provides greater protection regarding the coverage of orally administered anticancer medications, that state law will still apply regardless of the federal law.
  • Definition of Cost-Sharing: The term 'cost-sharing' includes deductibles, coinsurance, copayments, and any maximum limits on these out-of-pocket costs.

Implementation Timeline

The new requirements will apply to health plans for plan years beginning on or after January 1, 2026.

Study Requirement

Within two years of the bill's enactment, the Government Accountability Office (GAO) will conduct a study to assess the impact of these new cost-sharing provisions. This study will compare out-of-pocket costs for individuals under the newly enforced sections with those who are not covered by them. The GAO will provide recommendations to Congress on how to improve access to these medications for individuals with health insurance plans.

Relevant Companies

  • AMGN (Amgen Inc.): Amgen manufactures several oral cancer medications and may be impacted by changes in cost-sharing policies required by the bill.
  • ABBV (AbbVie Inc.): AbbVie produces oral drugs for cancer treatment and could experience changes in demand based on insurance coverage modifications.
  • NVS (Novartis AG): Novartis markets oral anticancer therapies and may be affected by alterations in insurance plan structures regarding these drugs.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

13 bill sponsors

Actions

2 actions

Date Action
Jun. 24, 2025 Introduced in House
Jun. 24, 2025 Referred to the House Committee on Education and Workforce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Cliff Bentz R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 06, 2025 -3.10%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC. CMN
Purchase $15,001 - $50,000
Jun 10, 2025 May 28, 2025 -4.05%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 11, 2025 May 22, 2025 -4.58%
Congress pfp
Robert Bresnahan R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 09, 2025 May 15, 2025 -2.77%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 19, 2025 May 14, 2025 +5.65%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $15,001 - $50,000
Jun 22, 2025 May 12, 2025 -0.25%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -5.95%
Congress pfp
Marjorie Taylor Greene R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -15.34%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
May 14, 2025 Apr 17, 2025 -10.43%
Congress pfp
Jefferson Shreve R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $50,001 - $100,000
May 08, 2025 Apr 17, 2025 -10.43%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -14.85%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -14.85%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $15,001 - $50,000
May 15, 2025 Apr 15, 2025 -16.68%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -14.29%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC. CMN
Sale $15,001 - $50,000
May 12, 2025 Apr 09, 2025 -10.94%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 09, 2025 -14.09%
Congress pfp
Robert Bresnahan R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -19.10%
Congress pfp
Robert Bresnahan R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -20.83%
Congress pfp
Jared Moskowitz D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 07, 2025 -23.45%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC COM USD0.01
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -23.15%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC COM USD0.01
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -23.15%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC COM USD0.01
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -23.15%
Congress pfp
Dwight Evans D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
Apr 17, 2025 Apr 03, 2025 -23.29%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
May 14, 2025 Apr 03, 2025 -23.29%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
May 14, 2025 Apr 01, 2025 -20.51%
Congress pfp
George Whitesides D / House
NVS logo
NVS STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. NOVARTIS AG COMMON STOCK
Sale $100,001 - $250,000
Apr 23, 2025 Mar 24, 2025 -0.30%
Congress pfp
Marjorie Taylor Greene R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 19, 2025 Mar 17, 2025 -22.77%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -20.14%
Congress pfp
Robert Bresnahan R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 -13.35%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -9.69%
Congress pfp
Jefferson Shreve R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $50,001 - $100,000
Mar 09, 2025 Feb 24, 2025 -12.81%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $15,001 - $50,000
Mar 06, 2025 Feb 19, 2025 -7.01%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -2.05%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 05, 2025 -5.72%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 05, 2025 -5.72%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 04, 2025 -5.22%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 04, 2025 -5.22%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 04, 2025 -5.22%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +7.60%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +4.42%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 +4.57%
Congress pfp
Jared Moskowitz D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +3.86%
Congress pfp
Jared Moskowitz D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +3.86%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +8.68%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +4.98%
Congress pfp
Virginia Foxx R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +3.46%
Congress pfp
Marjorie Taylor Greene R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Nov 21, 2024 Nov 20, 2024 +5.77%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -3.06%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 12, 2024 -6.33%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -16.37%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -11.21%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 11, 2024 -18.26%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -22.59%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Oct 04, 2024 Sep 09, 2024 -24.12%
Congress pfp
John James R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -18.34%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN C�������: OUR BROKER PURCHASED SHARES OF 29 STOCKS IN MY SPOUSE'S ROTH IRA ON 8/7/24 IN ORDER TO REBALANCE THE PORTFOLIO IN ACCORDANCE WITH THE FIRM'S INVESTMENT STRATEGY FOR ACCOUNTS THAT SIZE. HE FAILED TO NOTIFY ME OF THESE TRANSACTIONS AND IT WASN'T DISCOVERED UNTIL I WAS ATTEMPTING TO RECONCILE OUR INVESTMENT HOLDINGS FOR MY 2024 FINANCIAL DISCLOSURE. SP AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 03, 2025 Aug 07, 2024 -26.38%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -26.38%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 05, 2024 -19.24%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -29.15%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -29.15%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -29.15%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -18.26%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -18.26%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -1.03%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -19.22%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -19.22%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Jun 05, 2024 May 29, 2024 +2.19%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -19.53%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
May 06, 2024 Apr 23, 2024 -13.08%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
May 02, 2024 Apr 10, 2024 -10.72%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Sale (Partial) $1,001 - $15,000
May 20, 2024 Apr 09, 2024 +5.08%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Purchase $1,001 - $15,000
May 15, 2024 Apr 03, 2024 -14.69%
Congress pfp
Ro Khanna D / House
NVS logo
NVS NOVARTIS AG-ADR SPONSORED ADR CMN
Exchange None
Mar 06, 2024 Mar 05, 2024 -
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -17.05%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -33.94%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -33.97%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Sale (Full) $1,001 - $15,000
Feb 14, 2024 Jan 19, 2024 -15.88%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Feb 05, 2024 Jan 10, 2024 -17.54%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $15,001 - $50,000
Feb 05, 2024 Jan 10, 2024 -17.54%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -33.40%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Dec 18, 2023 Dec 08, 2023 -10.36%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $1,001 - $15,000
Jan 04, 2024 Dec 05, 2023 -7.36%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Sale $15,001 - $50,000
Jan 04, 2024 Dec 04, 2023 -6.94%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV Abbvie Inc
Sale (Full) $1,001 - $15,000
Dec 15, 2023 Nov 20, 2023 -2.23%
Congress pfp
John James R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 -6.76%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Dec 08, 2023 Nov 08, 2023 -11.14%
Congress pfp
Greg Stanton D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -19.54%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -41.00%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Purchase $1,001 - $15,000
Nov 16, 2023 Oct 17, 2023 -17.81%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Nov 08, 2023 Oct 02, 2023 -19.91%
Congress pfp
Robert J. Wittman R / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Oct 19, 2023 Sep 28, 2023 -22.85%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -36.88%
Congress pfp
Greg Stanton D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -24.50%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Purchase $15,001 - $50,000
Oct 17, 2023 Sep 20, 2023 -25.82%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -14.61%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $15,001 - $50,000
Oct 06, 2023 Sep 06, 2023 -11.45%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Oct 10, 2023 Sep 06, 2023 -11.45%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Oct 10, 2023 Aug 30, 2023 -12.34%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV "ABBVIE INC CMN
Purchase $1,001 - $15,000
Sep 06, 2023 Aug 29, 2023 -12.30%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC.
Sale $15,001 - $50,000
Sep 05, 2023 Aug 14, 2023 -16.49%
Congress pfp
Michael Guest R / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Aug 23, 2023 Aug 07, 2023 -14.12%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $15,001 - $50,000
Sep 06, 2023 Aug 03, 2023 -13.61%
Congress pfp
Ro Khanna D / House
ABBV logo
ABBV ABBVIE INC CMN
Purchase $1,001 - $15,000
Aug 07, 2023 Jul 28, 2023 -12.64%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Aug 21, 2023 Jul 27, 2023 -12.31%